RABEPRAZOLE Manufacturer Supplier in PCD Pharma Franchise
BRAND NAME FOR RABEPRAZOLE IN PCD PHARMA FRANCHISE – ROSIRAB IV
COMPOSITION: RABEPRAZOLE 20MG IV
For rates and Schemes – Contact 8284010553
Introduction of RABEPRAZOLE
Rosirab IV, developed by Matins Pharma, delivers the therapeutic benefits of Rabeprazole 20mg intravenously, offering a potent solution for gastric acid suppression. Matins Pharma, a leading supplier in PCD Pharma Franchise and Third-Party Manufacturing, adheres to stringent quality standards to ensure the efficacy and safety of pharmaceutical products. Rosirab IV stands as a reliable option for the management of acid-related gastrointestinal disorders, providing patients with relief from symptoms and promoting overall digestive health.
Uses of RABEPRAZOLE
Rabeprazole 20mg IV, encapsulated in Rosirab IV, serves a crucial role in the treatment of various acid-related gastrointestinal conditions. As a proton pump inhibitor (PPI), Rabeprazole effectively suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase pump in the gastric parietal cells. Rosirab IV finds utility in conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and Helicobacter pylori eradication therapy. By reducing gastric acidity, Rosirab IV alleviates symptoms such as heartburn, acid reflux, and gastric ulcers, improving patients’ quality of life.
Side Effects of RABEPRAZOLE
While Rosirab IV is generally well-tolerated, it’s essential to be aware of potential side effects that may occur. Common side effects of Rabeprazole 20mg IV may include headache, nausea, vomiting, abdominal pain, or diarrhea. In rare cases, individuals may experience allergic reactions such as rash, itching, or swelling. Prolonged use of proton pump inhibitors like Rabeprazole may increase the risk of certain adverse effects, including bone fractures, vitamin B12 deficiency, or Clostridium difficile-associated diarrhea. Patients should promptly report any adverse reactions to healthcare providers for evaluation and management.
Safety Advice of RABEPRAZOLE
Ensuring patient safety is paramount when administering Rosirab IV. Healthcare professionals should exercise caution when prescribing Rabeprazole to patients with known allergies to PPIs or any components of the formulation. Patients with severe hepatic impairment may require dose adjustments or alternative treatment options. Long-term use of Rosirab IV should be carefully evaluated, considering the potential risks of adverse effects. Healthcare providers should monitor patients regularly for symptoms of vitamin B12 deficiency, osteoporosis, or other complications associated with prolonged PPI therapy.
Dosage of RABEPRAZOLE
The dosage of Rosirab IV may vary depending on the specific condition being treated and the patient’s individual response to therapy. In general, the recommended dose for adults is one vial of Rosirab IV (containing Rabeprazole 20mg IV) administered intravenously once daily. The duration of treatment may vary depending on the severity and chronicity of the underlying condition. Healthcare providers should adjust the dosage regimen based on patient characteristics and closely monitor their response to therapy.
The onset of action of Rabeprazole 20mg IV in Rosirab IV typically occurs within 1 to 2 hours following administration, with peak effects observed within 2 to 4 hours. Patients may experience relief from symptoms such as heartburn and acid reflux shortly after receiving Rosirab IV. However, complete healing of peptic ulcers or resolution of other gastrointestinal conditions may take several weeks of continuous therapy. It’s essential for patients to adhere to the prescribed treatment regimen and follow-up with healthcare providers for monitoring of symptoms and potential adjustments to therapy.
MATINS PHARMA IS A LEADING MANUFACTURER / SUPPLIER OF RABEPRAZOLE
Matins Pharma, a leading manufacturer and supplier in the pharmaceutical industry, offers high-quality RABEPRAZOLE 20MG IV under the brand name ROSIRAB IV.
Matins Pharma is one of the fastest growing Manufacturers suppliers pan India.
WE AT MATINS PHARMA AIM FOR :
- 100% quality assurance with high efficacy and excellent results
- Improved delivery experience and shorter delivery times
- Best in class service levels through regular communication with our Supplier partners and sharing the same in a transparent manner
- Customer satisfaction and understanding the latent needs of the our business partners
- Enriching our product mix by each passing day so as to provide you everything under one roof
Why Matins Pharma is among the best PCD Pharma Franchise Company in India:
- 100 % Quality Assurance
- Direct Dealing with Company Owners
- Very High Efficacy, WHO/GMP/GLP Certified Products
- Wide Product Range
- Best in Class Packings with UV Drip Off Finish
- High Margin Products with genuine rates
- Same Day Dispatch with trusted delivery partners
- Fair and Transparent Dealing – 100 % Commitment to agreement
Address: D-1A, Ahluwalia Complex Vill. Fatehpur, Sector 20, Panchkula, 134117, Haryana
Contact Number: 82840 10553, 99155 69932, 94175 06219India
We at Matins Pharma provide wide range of quality products. We offer the following ranges in PCD Pharma Franchise:
